-
Kitsap Respiratory Illness Report: Nov. 12 to Nov. 18
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, News and Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 46 of the Kitsap Respiratory Illness Report. In the week ending on Nov. 18, Kitsap Public Health District saw increasing numbers of labs positive for respiratory syncytial virus (RSV) and influenza reported by our sentinel respiratory reporting laboratories, indicating that RSV and flu are rising locally. Local COVID-19 indicators remain low.…
-
Health Advisory: Nirsevimab supplies limited
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Provider Resources, VaccineNov. 22, 2023 Washington is scheduled to receive 7,700 50 mg and 600 100 mg Pfizer nirsevimab doses for the remainder of respiratory syncytial virus (RSV) season. The CDC released a Health Alert that provides guidance for healthcare providers. See the background section below for details. ACTIONS REQUESTED Immunize.org released a standing order template for this RSV season to ensure…
-
Kitsap Respiratory Illness Report: Nov. 12 to Nov. 18
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, News and Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 46 of the Kitsap Respiratory Illness Report. In the week ending on Nov. 18, Kitsap Public Health District saw increasing numbers of labs positive for respiratory syncytial virus (RSV) and influenza reported by our sentinel respiratory reporting laboratories, indicating that RSV and flu are rising locally. Local COVID-19 indicators remain low.…
-
Health Advisory: Nirsevimab supplies limited
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Provider Resources, VaccineNov. 22, 2023 Washington is scheduled to receive 7,700 50 mg and 600 100 mg Pfizer nirsevimab doses for the remainder of respiratory syncytial virus (RSV) season. The CDC released a Health Alert that provides guidance for healthcare providers. See the background section below for details. ACTIONS REQUESTED Immunize.org released a standing order template for this RSV season to ensure…
-
Kitsap Respiratory Illness Report: June 25-July 22
Advisory or Update, Communicable Disease Data Report, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access weeks 26 through 29 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently low, with 5 positive influenza tests in the past four weeks (1,766 cumulative (12% of total tested) since 10/2/2022). RSV activity is currently low, with 0 positive RSV tests in the past four weeks (500 since…
-
Washington State Department of Health investigating first case of Candida auris diagnosed locally
Advisory or Update, Emerging Diseases and Conditions, Health Advisory, Health Alert, Infection Control, Provider ResourcesACTIONS REQUESTED BACKGROUND A patient in a Washington healthcare facility with was recently reported to have C. auris. Based on known details, the state Department of Health believe (DOH) believes this case of C. auris was acquired in Washington. The Tacoma-Pierce County Health Department is investigating the case. DOH is also aware of one other unrelated…
-
Kitsap Public Health Board declares crisis in response to high healthcare costs and inadequate access to services
The resolution commits the Board and Health District to advance a public health approach to addressing costs and barriers to accessing care. KITSAP COUNTY, WA — The Kitsap Public Health Board discussed and unanimously approved resolution on July 11 declaring high healthcare costs and insufficient access to healthcare services in Kitsap County public health crises.…
-
Kitsap Respiratory Illness Report: May 28 – June 24
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access weeks 22 through 25 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently elevated, with 27 positive influenza tests in the past four weeks (1,760 cumulative (13% of total tested) since 10/2/2022). RSV activity is currently low, with 1 positive RSV test in the past four weeks (499 since…
-
Health advisory: Bicillin® L-A (Benzathine Penicillin G) shortage anticipated through the end of year
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Health Alert, Immunization, Immunizations, Infection Control, PreventionActions requested Background Pfizer pharmaceuticals has reported a shortage of benzathine penicillin (Bicillin® L-A) due to increased demand for the drug related to the growing national and international epidemic of syphilis. Pfizer is the sole supplier of benzathine penicillin in the U.S. Local medical providers have alerted Public Health that they have had trouble securing benzathine penicillin…
-
Kitsap Respiratory Illness Report: April 30 – May 27
Advisory or Update, Communicable Disease Data Report, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access weeks 18 through 21 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently low, with 11 positive influenza tests in the past four weeks (1,733 cumulative (13% of total tested) since 10/2/2022). RSV activity is currently low, with 3 positive RSV tests in the past four weeks (498 since…
-
Health advisory: Potential risk for new mpox cases; encourage JYNNEOS vaccination
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Health Alert, Immunization, Immunizations, Infection Control, monkeypox, News and Alerts, News and Update, Prevention, Provider ResourcesActions requested Background A global outbreak of mpox began in May 2022. Previous outbreaks in places where mpox is not endemic were mostly related to international travel; however, this outbreak spread rapidly across much of the world through person-to-person contact, disproportionately affecting gay and bisexual men, other men who have sex with men (MSM), and transgender…
-
Help us improve our healthcare communications
We need your feedback! We work hard to ensure our communications with Kitsap healthcare providers are accurate, timely, and useful. However, we know there is always room for improvement. We would appreciate it if you could take a few minutes to provide feedback on our communications and how we can effectively collaborate with our healthcare…
-
Kitsap Respiratory Illness Report: April 2 – April 29
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Novel Coronavirus, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access weeks 14 through 17 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently low, with 11 positive influenza tests in the past four weeks (1,722 cumulative (14% of total tested) since 10/2/2022). RSV activity is currently low, with 3 positive RSV tests in the past week (495 since the…
-
CDC endorses expanded use of bivalent COVID vaccines; original mRNA vaccines no longer authorized
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Immunization, Immunizations, Infection Control, News and Alerts, News and Update, Novel Coronavirus, Provider Resources, VaccineThe CDC shared simplified recommendations for COVID-19 vaccination this week based on new rules issued by the FDA. Important guidance changes include: Additional notes and updates The fact sheets for Healthcare Professionals, Recipients, and Caregivers were updated for Pfizer-BioNTech COVID-19 Vaccines and Moderna COVID-19 Vaccines. The CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines page will be updated soon…
-
Kitsap Respiratory Illness Report: March 26 – April 1
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 13 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently low, with 1 positive influenza test in the past week (1,711 cumulative (15.0% of total tested) since 10/2/2022). RSV activity is currently low, with 1 positive RSV test in the past week (492 since the start of the season).…
-
Kitsap Respiratory Illness Report: March 19 – March 25
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 12 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently low, with 3 positive influenza tests in the past week (1,710 cumulative (15.5% of total tested) since 10/2/2022). RSV activity is currently low, with 0 positive RSV tests in the past week (491 since the start of the…